● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.7 for the 2019 fiscal year.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The stock is in a well-established, long-term rising trend above the technical support level at 9.78 USD
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at USD 14.35.
● The stock is close to a major daily resistance at USD 14.6, which should be gotten rid of so as to gain new appreciation potential.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company sustains low margins.
● The group shows a rather high level of debt in proportion to its EBITDA.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● With a 2019 P/E ratio at 29.21 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
● For the past year, analysts have significantly revised downwards their profit estimates.